Welcome to PwC’s monthly issue of the Life Sciences Newsbrief. This publication will provide you with a snapshot of developments in the Canadian and global life sciences industry along with upcoming Canadian events and thought leadership. If you need further information, please contact any of the life sciences professionals listed on the right.
R&D Tax Trends: Creating a Climate for Innovation
Global R&D Tax News, July - Issue 2
As countries focus on maintaining economic balance and hope for steady economic growth, R&D tax incentives have become popular ways to attract investments. Recently, several countries have introduced or propose to introduce incentives for R&D activities in their governments to increase their global competitiveness.
This issue highlights recent changes undertaken in a few countries along with developments that may impact R&D planning around the world. Developments include: United Kingdom R&D reform, joint audits, Canada Revenue Agency documentation guidelines, Ireland tax changes, and United States issuance of final regulations that impact the calculation of the Alternative Simplified Credit. Click here to download this publication.
2011 MoneyTree™ report summary
The Q2 2011 MoneyTree™ results are in! This special report provides summary results of Q2 2010, Q1 2011, and Q2 2011. More detailed results, including an expanded version of this report, can be found on the MoneyTree™ website at www.pwcmoneytree.com.
Introducing Pharma 2020 Series: Executive Summary
The executive summary provides an overview of the Pharma 2020 series. The reports look into the future of the Pharmaceuticals and Life Sciences’ value chain and include an analysis of the strategies available to companies. The challenges and opportunities the industry will face are described and what changes are necessary to capitalise on them. Click here to download the full reports.
Medicaid Drug Rebate Summit
September 14-16, Chicago, IL
PwC is a sponsor.
Eighth National Biotechnology Week
September 16-23, Across Canada
National Biotechnology Week partners help BIOTECanada and the national organizers put on a week that excites, engages and educates Canadians about the power — and the promise — of biotechnology.
Risk Evaluation & Mitigation Strategies (REMS Experience)
September 28, 2011, 11:00am EST
Join Karla Anderson and Joseph Philipose from PwC's Pharmaceutical and Life Sciences Advisory team as they present perspectives on optimizing the Multi-Sponsor REMS (Risk Evaluation & Mitigation Strategies) Experience and its impact on life sciences and pharma companies. Registration link will come in the next issue of the Life Sciences Newsbrief.